· Periodic Report
Q3 revenue KRW 1.9 billion, operating loss KRW 2.7 billion
Penitrium Bio sold KRW 1.9 billion worth in Q3 and lost KRW 2.7 billion from its main business, versus a KRW 1.5 billion loss a year earlier.
187660 · KOSDAQ · Based on DART filings
2 total · 20 per page
· Periodic Report
Penitrium Bio sold KRW 1.9 billion worth in Q3 and lost KRW 2.7 billion from its main business, versus a KRW 1.5 billion loss a year earlier.
· Report on Large Shareholdings
HYUNDAI BIOSCIENCE CO., LTD.'s group stake in Penetrium Bioscience Inc. stays at 37.57%, while shares under pledge contracts changed from 13,070,000 to 12,850,000.
Get app alerts for new disclosures from Penetrium Bioscience Inc..